
Keywords: DES; drug-eluting stent(s); HbA1c; impaired glucose tolerance; OGTT; oral glucose tolerance testing; PCI; percutaneous coronary intervention; silent diabetes; DES; drug-eluting stent(s); DM; diabetes mellitus; FPG; fasting plasma glucose; IFG; impaired f